Study Evaluating the Safety and Pharmacokinetics of a Single Dose of GSI-953
NCT00441987
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
96
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
GSI-953
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer